Indianapolis, IN, United States of America

Sarah E Canada

This inventor holds 1 USPTO granted patent. Top assignee: Dow Agrosciences LLC. Active years: 2017.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sarah E Canada

Introduction

Sarah E Canada is an accomplished inventor based in Indianapolis, IN (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for various applications, including agricultural biotechnology.

Latest Patents

Sarah E Canada holds a patent for "Monoclonal antibodies specific for Cry1Ca and related detection methods." This patent describes murine monoclonal antibodies and methods that are useful for determining and quantifying the presence of Cry1Ca delta endotoxin. The claimed antibodies specifically bind the core toxin region, making them suitable for detecting the native full-length Cry1Ca toxin as well as the amino core toxin and N-terminal 29 residue truncated forms. She has 1 patent to her name.

Career Highlights

Sarah is currently employed at Dow Agrosciences LLC, where she continues to innovate and contribute to advancements in agricultural science. Her expertise in monoclonal antibodies has positioned her as a key player in her field.

Collaborations

Throughout her career, Sarah has collaborated with notable colleagues, including Eric Hongzheng Ma and Guomin Shan. These partnerships have enhanced her research and expanded the impact of her work.

Conclusion

Sarah E Canada exemplifies the spirit of innovation in biotechnology through her groundbreaking work on monoclonal antibodies. Her contributions are vital to the ongoing advancements in agricultural applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…